USFDA authorized a booster dose of the Pfizer and #BioNTech COVID-19 vaccine for those 65 and older, all people at high risk of severe disease, & others.
Read at 👇
https://www.moneycontrol.com/news/world/us-fda-clears-pfizer-covid-19-booster-for-older-and-at-risk-americans-7497001.html?utm_source=telegram&utm_medium=social
Read at 👇
https://www.moneycontrol.com/news/world/us-fda-clears-pfizer-covid-19-booster-for-older-and-at-risk-americans-7497001.html?utm_source=telegram&utm_medium=social
Moneycontrol
US FDA Clears Pfizer COVID-19 Booster For Older And At-risk Americans
The decision paves the way for a quick rollout of the booster shots as soon as this week for millions of people who had their second dose of the vaccine at least six months ago.
#Pfizer and #BioNtech are set to displace AstraZeneca as the main suppliers of #COVID19Vaccines to the global #COVAX programme at the start of 2022.
Read more:
https://www.moneycontrol.com/news/trends/health-trends/pfizer-set-to-oust-astrazeneca-as-top-supplier-of-covid-19-shots-to-poor-nations-7827751.html?utm_source=telegram&utm_medium=social
Read more:
https://www.moneycontrol.com/news/trends/health-trends/pfizer-set-to-oust-astrazeneca-as-top-supplier-of-covid-19-shots-to-poor-nations-7827751.html?utm_source=telegram&utm_medium=social
Moneycontrol
Pfizer Set To Oust AstraZeneca As Top Supplier Of COVID-19 Shots To Poor Nations
The expected change comes with headaches for receiving countries that lack sufficient cold storage capacity to handle the Pfizer vaccine, and amid risks of a shortage of syringes needed to administer that shot.
The U.S. Food and Drug Administration has authorized the use of a booster shot of #Pfizer and #BioNTech's COVID-19 vaccine for children aged 5 to 11.
Read more 👇
https://www.moneycontrol.com/news/world/us-fda-authorizes-pfizers-covid-booster-shot-for-young-children-8526281.html?utm_source=telegram&utm_medium=social
Read more 👇
https://www.moneycontrol.com/news/world/us-fda-authorizes-pfizers-covid-booster-shot-for-young-children-8526281.html?utm_source=telegram&utm_medium=social
Moneycontrol
US FDA authorizes Pfizer's COVID booster shot for young children
The authorization makes everyone in the United States aged five and above eligible for booster doses of the vaccine.